- Standards & Trade >
- WTO TBT Inquiry Point >
- U.S. Notifications >
U.S. Notifications
United States of America (USA/165: Barley and barley-containing foods (HS 1101, 1102, 1103, 1104))
The Food and Drug Administration (FDA) is amending the existing regulation authorizing the use on food labels of a health claim about beta-glucan soluble fiber from whole oat foods and risk of heart disease, to include whole grain barley and dry milled barley products as additional eligible sources of beta-glucan soluble fiber. Based on the totality of publicly available scientific evidence, FDA has determined that blood cholesterol-lowering effects of oats and barley are equivalent. Therefore, FDA has concluded that consuming beta-glucan-containing whole grain barley or certain dry milled barley products may help reduce blood cholesterol levels, and FDA is amending 21 CFR 101.81 to include whole grain barley and certain dry milled barley products as substances eligible for the soluble dietary fiber- heart disease risk health claim.
Full Text
Final Comment Date: March, 08, 2006
(Texts provided by the World Trade Organization.)
updates delivered to your desktop
We have provided a link to this site because it has information that may be of interest to our users. NIST does not necessarily endorse the views expressed or the facts presented on this site. Further, NIST does not endorse any commercial products that may be advertised or available on this site.